SCHEMBL3383496

SCHEMBL3383496

CCN(CC)CCOc1c[nH]c2ccc(N)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.45
CYP1A2 P05177 1/20 0.45
SCN1A P35498 1/20 0.45
SCN2A Q99250 1/20 0.45
SCN3A Q9NY46 1/20 0.45
PIM1 P11309 3/20 0.43
HTR1A P08908 2/20 0.43
PIM3 Q86V86 2/20 0.43
PIM2 Q9P1W9 2/20 0.43
MPO P05164 3/20 0.42
HTR1D P28221 2/20 0.42
BIRC5 O15392 1/20 0.42
MAOA P21397 2/20 0.40
HTR3A P46098 2/20 0.40
HRH3 Q9Y5N1 2/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2C P28335 1/20 0.40
CHRNA4 P43681 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382239 0.84 SLC6A4 (0.45) PIM1HTR1APIM3PIM2MPO
SCHEMBL3383870 0.75 HTR1D (0.46) CYP2D6CYP1A2HTR1AHTR1DBIRC5
SCHEMBL11233185 0.75 KDM4E (0.65) CYP2D6CYP1A2SCN1ASCN2ASCN3A
SCHEMBL13496586 0.75 KDM4E (0.41) CYP2D6CYP1A2SCN1ASCN2ASCN3A
SCHEMBL3857789 0.74 BIRC5 (0.51) CYP2D6CYP1A2SCN1ASCN2ASCN3A
SCHEMBL4008111 0.74 PRKCI (0.56) CYP2D6CYP1A2SCN1ASCN2ASCN3A
Hydrochloric Acid SCHEMBL11225332 0.74 MAPT (0.68) CYP2D6CYP1A2SCN1ASCN2ASCN3A
SCHEMBL3383493 0.73 TUBB4A (0.39) CYP2D6CYP1A2HTR1AHTR1DHTR2C
SCHEMBL3616464 0.73 BIRC5 (0.54) CYP2D6CYP1A2SCN1ASCN2ASCN3A
SCHEMBL6807627 0.73 CYP2D6 (0.53) CYP2D6CYP1A2SCN1ASCN2ASCN3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2149573-A1 Substituted indole sulfonamide compounds their preparation and use as medicaments Laboratorios Del. Dr. Esteve, S.A. (ES) 2010-02-03 EP disclosed